Estrogen Deficiency Accelerates Murine Autoimmune Arthritis Associated with Receptor Activator of Nuclear Factor-κB Ligand-Mediated Osteoclastogenesis
The DOI matches its Crossref record; 55 of the 57 references it cites were found in a registry or an index.
Abstract
The aims of this study were to evaluate the in vivo effects of estrogen deficiency in MRL/lpr mice as a model for rheumatoid arthritis and to analyze the possible relationship between immune dysregulation and receptor activator of nuclear factor-kappaB ligand (RANKL)-mediated osteoclastogenesis. Experimental studies were performed in ovariectomized (Ovx)-MRL/lpr, Ovx-MRL+/+, sham-operated-MRL/lpr, and sham-operated-MRL+/+ mice. Severe autoimmune arthritis developed in younger Ovx-MRL/lpr mice until 24 wk of age, whereas these lesions were entirely recovered by pharmacological levels of estrogen administration. A significant elevation in serum rheumatoid factor, anti-double-stranded DNA, and anti-type II collagen was found in Ovx-MRL/lpr mice and recovered in mice that underwent estrogen administration. A high proportion of CD4(+) T cells bearing RANKL was found, and an enhanced expression of RANKL mRNA and an impaired osteoprotegerin mRNA was detected in the synovium. An increase in both osteoclast formation and bone resorption pits was found. These results indicate that estrogen deficiency may play a crucial role in acceleration of autoimmune arthritis associated with RANKL-mediated osteoclastogenesis in a murine model for rheumatoid arthritis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“OVX has been shown to increase RANKL levels in various animal models (50, 198 -201).”
From Receptor Activator of Nuclear Factor κB Ligand and Osteoprotegerin Regulation of Bone Remodeling in Health and Disease (2008) · cites this paper as [198]
In the citing paper
“OPG levels have been reported to increase (199) or decrease (198,201) in association with OVX, and this difference in response could relate to variations in the animal model and/or the tissue source analyzed.”
From Receptor Activator of Nuclear Factor κB Ligand and Osteoprotegerin Regulation of Bone Remodeling in Health and Disease (2008) · cites this paper as [198]
Citations
Cites
A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function.
Anderson, D. M., Maraskovsky, E., Billingsley, W. L., Dougall, W. C., Tometsko, M. E., Roux, E. R., Teepe, M. C., DuBose, R. F., Cosman, D., & Galibert, L. (1997) · Nature · doi:10.1038/36593 · Cited by 2,290
Cytokine Pathways and Joint Inflammation in Rheumatoid Arthritis
Choy, E. H. S., & Panayi, G. S. (2001) · New England Journal of Medicine · doi:10.1056/nejm200103223441207 · Cited by 2,249
Kong, Y.-Y., Feige, U., Sarosi, I., Bolon, B., Tafuri, A., Morony, S., Capparelli, C., Li, J., Elliott, R., McCabe, S., et al. (1999) · Nature · doi:10.1038/46303 · Cited by 1,856
Therapeutic Approaches to Bone Diseases
Rodan, G. A., & Martin, T. J. (2000) · Science · doi:10.1126/science.289.5484.1508 · Cited by 1,767
Murine Models of Systemic Lupus Erythematosus
Theofilopoulos, A. N., & Dixon, F. J. (1985) · Advances in Immunology · doi:10.1016/s0065-2776(08)60342-9 · Cited by 1,550
Increased Osteoclast Development After Estrogen Loss: Mediation by Interleukin-6
Jilka, R. L., Hangoc, G., Girasole, G., Passeri, G., Williams, D. C., Abrams, J. S., Boyce, B., Broxmeyer, H., & Manolagas, S. C. (1992) · Science · doi:10.1126/science.1621100 · Cited by 1,442
lpr And gld: Single Gene Models Of Systemic Autoimmunity And Lymphoproliferative Disease
Cohen, P. (1991) · Annual Review of Immunology · doi:10.1146/annurev.immunol.9.1.243 · Cited by 1,196
Udagawa, N., Takahashi, N., Akatsu, T., Tanaka, H., Sasaki, T., Nishihara, T., Koga, T., Martin, T. J., & Suda, T. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.18.7260 · Cited by 1,048
Wong, B. R., Rho, J., Arron, J., Robinson, E., Orlinick, J., Chao, M., Kalachikov, S., Cayani, E., Bartlett, F. S., Frankel, W. N., et al. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.40.25190 · Cited by 1,042
Davidson, A., & Diamond, B. (2001) · New England Journal of Medicine · doi:10.1056/nejm200108023450506 · Cited by 1,042
Research works printed but not linked: 5
- Pap, 2000, Differential expression pattern of membrane-type matrix metalloproteinases in rheumatoid arthritis., Arthritis Rheum, 43, 1226, 10.1002/1529-0131(200006)43:6<1226::AID-ANR5>3.0.CO;2-4 · DOI · Paper page
- Takayanagi, 2000, Involvement of receptor activator of nuclear factor κB ligand/osteoclast differentiation factor in osteoclastogenesis from synoviocytes in rheumatoid arthritis., Arthritis Rheum, 43, 259, 10.1002/1529-0131(200002)43:2<259::AID-ANR4>3.0.CO;2-W · doi:10.1002/1529-0131(200002)43:2<259::aid-anr4>3.0.co;2-w
- Kotake, 2001, Activated human T cells directly induce osteoclastogenesis from human monocytes: possible role of T cells in bone destruction in rheumatoid arthritis patients., Arthritis Rheum, 44, 1003, 10.1002/1529-0131(200105)44:5<1003::AID-ANR179>3.0.CO;2-# · DOI · Paper page
- Gravallese, 2000, Synovial tissue in rheumatoid arthritis is a source of osteoclast differentiation factor., Arthritis Rheum, 43, 250, 10.1002/1529-0131(200002)43:2<250::AID-ANR3>3.0.CO;2-P · doi:10.1002/1529-0131(200002)43:2<250::aid-anr3>3.0.co;2-p
- Romas, 2000, Expression of osteoclast differentiation factor at sites of bone erosion in collagen-induced arthritis., Arthritis Rheum, 43, 821, 10.1002/1529-0131(200004)43:4<821::AID-ANR12>3.0.CO;2-T · doi:10.1002/1529-0131(200004)43:4<821::aid-anr12>3.0.co;2-t
Cited by
The complex role of estrogens in inflammation
Straub, R. H. (2007) · Endocrine Reviews · doi:10.1210/er.2007-0001 · Cited by 1,950
Kearns, A. E., Khosla, S., & Kostenuik, P. J. (2008) · Endocrine Reviews · doi:10.1210/er.2007-0014 · Cited by 824
Reactive Oxygen Species Stimulates Receptor Activator of NF-κB Ligand Expression in Osteoblast
Bai, X.-C., Lu, D., Liu, A.-L., Zhang, Z.-M., Li, X.-M., Zou, Z.-P., Zeng, W.-S., Cheng, B.-L., & Luo, S.-Q. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m409332200 · Cited by 319
Pettit, A. R., Walsh, N. C., Manning, C., Goldring, S. R., & Gravallese, E. M. (2006) · Rheumatology · doi:10.1093/rheumatology/kel045 · Cited by 151
“RANKL and RANK protein expression have been demonstrated in inflamed synovium near sites of bone erosion in animal models of RA [36–42].”
BackgroundIsoflavones—Safe food additives or dangerous drugs?
Wuttke, W., Jarry, H., & Seidlová‐Wuttke, D. (2007) · Ageing Research Reviews · doi:10.1016/j.arr.2007.05.001 · Cited by 174
Ominsky, M. S., Li, X., Asuncion, F. J., Barrero, M., Warmington, K. S., Dwyer, D., Stolina, M., Geng, Z., Grisanti, M., Tan, H.-L., et al. (2008) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.080109 · Cited by 131
Sasaki, H., Okamatsu, Y., Kawai, T., Kent, R., Taubman, M. A., & Stashenko, P. (2004) · Journal of Periodontal Research · doi:10.1111/j.1600-0765.2004.00760.x · Cited by 154
Osteoimmunology at the nexus of arthritis, osteoporosis, cancer, and infection
Jones, D., Glimcher, L. H., & Aliprantis, A. O. (2011) · Journal of Clinical Investigation · doi:10.1172/jci46262 · Cited by 91
Xiao, B., Liu, X., & Link, H. (2004) · Steroids · doi:10.1016/j.steroids.2004.05.019 · Cited by 73
Inhibition of Osteoporosis in Autoimmune Disease Prone MRL/Mpj-FaslprMice by N-3 Fatty Acids
Bhattacharya, A., Rahman, M., Banu, J., Lawrence, R. A., McGuff, H. S., Garrett, I. R., Fischbach, M., & Fernandes, G. (2005) · Journal of the American College of Nutrition · doi:10.1080/07315724.2005.10719466 · Cited by 57
“showed that estrogen deficiency caused by ovariectomy can profoundly increase the incidence of arthritis in MRL/lpr mice whereas the administration of estrogen prevented the development of arthritis and decreased RANKL expression in synovial tissue [67].”
BackgroundInterference with immune‐cell‐mediated bone resorption in periodontal disease
Han, X., Kawai, T., & Taubman, M. A. (2007) · Periodontology 2000 · doi:10.1111/j.1600-0757.2007.00215.x · Cited by 70
Ganesan, K., Balachandran, C., Manohar, B. M., & Puvanakrishnan, R. (2008) · Bone · doi:10.1016/j.bone.2008.05.025 · Cited by 48
“But, extensive clinical [5–7] and experimental [8–10] studies have demonstrated the protective effects of estrogen.”
BackgroundSkeletal and extraskeletal actions of denosumab
Sinningen, K., Tsourdi, E. A., Rauner, M., Rachner, T. D., Hamann, C., & Hofbauer, L. C. (2012) · Endocrine · doi:10.1007/s12020-012-9696-x · Cited by 55
Osteoinmunología: el estudio de la relación entre el sistema inmune y el tejido óseo
Arboleya, L. R., & Castañeda, S. (2013) · Reumatología Clínica · doi:10.1016/j.reuma.2013.02.008 · Cited by 62
Osteoimmunology: The Study of the Relationship Between the Immune System and Bone Tissue
Arboleya, L. R., & Castañeda, S. (2013) · Reumatología Clínica (English Edition) · doi:10.1016/j.reumae.2013.02.004 · Cited by 67
Estrogen and Testosterone Attenuate Extracellular Matrix Loss in Collagen-Induced Arthritis in Rats
Ganesan, K., Tiwari, M., Balachandran, C., Manohar, B. M., & Puvanakrishnan, R. (2008) · Calcified Tissue International · doi:10.1007/s00223-008-9183-9 · Cited by 44
“Sex steroids have a significant impact on the development of autoimmune diseases in humans and rodents [ 5 ].”
BackgroundHajati, A., Alstergren, P. J., Näsström, K., Bratt, J., & Kopp, S. (2009) · Journal of Oral and Maxillofacial Surgery · doi:10.1016/j.joms.2009.04.056 · Cited by 43
Su, S.-J., Yeh, Y., & Shyu, H.-W. (2013) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2013/594857 · Cited by 41
“Ovariectomy has been shown to increase RANKL levels and decrease OPG levels in various animal models [28, 29].”
BackgroundOsteoprotective effect of soybean and sesame oils in ovariectomized rats via estrogen-like mechanism
El‐Wakf, A. M., Hassan, H. A., & Gharib, N. S. (2013) · Cytotechnology · doi:10.1007/s10616-013-9580-4 · Cited by 43
“Other investigators have focused on the possible involvement of inflammatory cytokines, such as tumor necrosis factor-a (TNF-a), interleukin-1 (IL-1) and IL-6 in stimulating bone resorption under estrogen deficiency conditions (Yoneda et al. 2004), thus, emphasizing a relation between inflammation and bone loss.”
BackgroundInfluentialRANKL inhibition for the management of patients with benign metabolic bone disorders
Anastasilakis, A. D., Toulis, K. A., Pοlyzos, S. A., & Terpos, E. (2009) · Expert Opinion on Investigational Drugs · doi:10.1517/13543780903048929 · Cited by 39
“In ovariectomized (OVX) animals, RANKL levels increase [28] while OPG levels have been reported both to increase [28] and decrease [29].”
BackgroundSubramanian, S., Tovey, M., Afentoulis, M. E., Krogstad, A. P., Vandenbark, A. A., & Offner, H. (2005) · Clinical Immunology · doi:10.1016/j.clim.2005.01.006 · Cited by 39
Choi, E. M. (2010) · Experimental and Toxicologic Pathology · doi:10.1016/j.etp.2010.08.008 · Cited by 37
Oestrogen deficiency modulates particle-induced osteolysis
Nich, C., Langlois, J., Marchadier, A., Vidal, C., Cohen-Solal, M. E., Petite, H., & Hamadouche, M. (2011) · Arthritis Research & Therapy · doi:10.1186/ar3381 · Cited by 35
“This finding appears paradoxical as clinical trials [14-16] and experimental studies [ 17 ,18] have demonstrated the protective effects of oestrogen against inflammatory processes, such as rheumatoid arthritis (RA).”
ResultEstrogen mediated differential protein regulation and signal transduction in rheumatoid arthritis
Chakraborty, D., Sarkar, A., Mann, S., Monu, M., Agnihotri, P., Saquib, M., Malik, S., Kumavat, R., Mathur, A., & Biswas, S. (2022) · Journal of Molecular Endocrinology · doi:10.1530/jme-22-0010 · Cited by 32
Yan, X., Maixner, D. W., Li, F., & Weng, H. (2017) · Journal of Neurochemistry · doi:10.1111/jnc.13952 · Cited by 31
“…mice, which are accompanied with increased protein expression of CSF-1 and IL-1b Similar to patients with SLE, MRL/lpr mice reportedly display a wide range of pathologic changes like arthritis (Yoneda et al. 2004; Cox et al. 2010), myositis (Edwards et al. 1986), vasculitis (Yamada et al. 2003).”
InfluentialEstrogen in Cardiovascular Disease during Systemic Lupus Erythematosus
Gilbert, E., & Ryan, M. J. (2014) · Clinical Therapeutics · doi:10.1016/j.clinthera.2014.07.021 · Cited by 24
Hutami, I. R., Tanaka, E. I., & Izawa, T. (2018) · Japanese Dental Science Review · doi:10.1016/j.jdsr.2018.09.004 · Cited by 23
Self-citationKim, K., Choi, U.-S., Lee, S.-D., Kim, K.-H., Chung, K., Chang, Y., Park, K., Lee, Y., & Kim, C. (2005) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2005.02.025 · Cited by 21
Viatchenko‐Karpinski, V., Kong, L., & Weng, H. (2021) · Glia · doi:10.1002/glia.24130 · Cited by 21
“…in SLE patients, MRL/lpr mice exhibit inflammation in multiple tissues (organs) such as joints (Cox et al., 2010; Greco et al., 2003; Grossman, 2009; Yoneda et al., 2004), muscles (Edwards et al., 1986), vasculatures (Yamada et al., 2003), and kidneys (Andrews et al., 1978; Yen et al., 2013).”
BackgroundThouverey, C., & Caverzasio, J. (2015) · Endocrinology · doi:10.1210/en.2015-1669 · Cited by 19
Straburzyńska‐Lupa, A., Nowak, A., Romanowski, W., Korman, P., & Pilaczyńska-Szczȩśniak, Ł. (2012) · Journal of Bone and Mineral Metabolism · doi:10.1007/s00774-012-0400-2 · Cited by 16
Hutami, I. R., Izawa, T., Mino-Oka, A., Shinohara, T., Mori, H., Iwasa, A., & Tanaka, E. I. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.07.006 · Cited by 16
Self-citationFigueroba, S. R., Franco, G. C. N., Omar, N. F., Groppo, M. F., & Groppo, F. C. (2015) · International Journal of Oral and Maxillofacial Surgery · doi:10.1016/j.ijom.2015.06.025 · Cited by 15
Sipos, W., Duvigneau, J. C., Schmoll, F., Exel, B., Hofbauer, G., Baravalle, G., Hartl, R. T., Dobretsberger, M., & Pietschmann, P. (2005) · Zentralblatt für Veterinärmedizin Reihe A · doi:10.1111/j.1439-0442.2005.00755.x · Cited by 16
Gallina, S., Piedra, S. B., Torrés-Lagares, D., Baroukh, B., Llorens, A., Pérez, J. L. G., Jl, S., Cherruau, M., & Lesclous, P. (2009) · Journal of Periodontology · doi:10.1902/jop.2009.090297 · Cited by 10
Sex Hormones and their Analogues in Neuroimmune Biology
Berczi, I., Laatikainen, R., & Pulkkinen, J. T. (2010) · Immunology Endocrine & Metabolic Agents - Medicinal Chemistry · doi:10.2174/187152210793292597 · Cited by 10
“Osteoclast increased and bone resorption pits were found [365].”
BackgroundThe p53-miR17 family-Rankl axis bridges liver-bone communication
Ma, G., Cheng, S., Han, Y., Tang, W., Pang, W., Chen, L., Ding, Z., & Cao, H. (2024) · Molecular Therapy · doi:10.1016/j.ymthe.2024.12.046 · Cited by 10
Regulation of intracellular Ca2+ by reactive oxygen species in osteoblasts treated with antimycin A
Choi, E. M. (2011) · Journal of Applied Toxicology · doi:10.1002/jat.1642 · Cited by 8
“Production of RANKL stimulated by ovariectomy results in increased osteoclasts formation and bone resorption in osteoporosis (Kodama et al., 2004) or autoimmune arthritis (Yoneda et al., 2004) mice.”
BackgroundMarana, R. R., dos Santos, V. A. B., Groppo, F. C., Ferreira, L. E. N., Sánchez, J. B., Barbin, T., & Figueroba, S. R. (2021) · Archives of Oral Biology · doi:10.1016/j.archoralbio.2021.105340 · Cited by 10
Helper T cells: A potential target for sex hormones to ameliorate rheumatoid arthritis? (Review)
Niu, Q., Hao, J., Li, Z., & Zhang, H. (2024) · Molecular Medicine Reports · doi:10.3892/mmr.2024.13339 · Cited by 7
“In MRL/lpr mice (with a genetic susceptibility similar to human RA), estrogen deficiency may induce the activation of RANKL‑carrying CD4+ T cells, leading to osteoclastogenesis and bone resorption (121).”
BackgroundNagai, K., Ishii, T., Ohno, T., & Nishii, Y. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2021.753754 · Cited by 6
“In general, because of the action of female hormones, female mice may not be suitable for accurate studies on bone metabolism or joint inflammation and bone tissue destruction; therefore, male mice were used in this experiment (21, 22).”
Method(2010) · Human Kinetics eBooks · doi:10.5040/9781492595700.ch-0011 · Cited by 6
Weng, H. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25073602 · Cited by 5
“As manifested in SLE patients, MRL / lpr mice have inflammation in multiple tissues (organs), including the joints [24,36–38], muscles [39], vascularies [40], kidneys [41,42], brain [43,44], and peripheral nerve [45].”
BackgroundCan estrogens promote hypertension during systemic lupus erythematosus?
Venegas‐Pont, M., & Ryan, M. J. (2010) · Steroids · doi:10.1016/j.steroids.2010.02.010 · Cited by 7
Prediction and prevention of rheumatoid arthritis
Huizinga, T. W. J., & Mil, A. H. M. V. D. H. (2007) · Revista Colombiana de Reumatología · Cited by 4
Anti-osteoporosis Effect of Cynaropicrin against Ovariectomy-induced Osteoporosis in Rats
Ye, H., Wang, K., & Li, K. (2023) · Pharmacognosy Magazine · doi:10.1177/09731296221137415 · Cited by 4
The Role of the Immune System in the Development of Osteoporosis
Mödder, U. I., Riggs, B. L., & Khosla, S. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-375670-1.10009-3 · Cited by 4
Guo, Y., Li, M., Zhusheng, L., Yamada, T., Sasaki, M., Hasegawa, T., Hongo, H., Tabata, C., Suzuki, R., Oda, K., et al. (2012) · Journal of Electron Microscopy · doi:10.1093/jmicro/dfs052 · Cited by 3
Research trends in estrogen and rheumatoid arthritis: a systematic bibliometric approach
Dai, X., Li, P., & Pan, D. (2025) · Biology of Sex Differences · doi:10.1186/s13293-025-00806-4 · Cited by 3
Bipin, S., Viatchenko‐Karpinski, V., Li, C., Lim, S., & Weng, H. (2025) · Cells · doi:10.3390/cells15010020 · Cited by 2
“Similarly to SLE patients, MRL/lpr mice exhibit inflammation in multiple organs, including joints [8–12], kidneys [13], and other tissues [14–16].”
The Role of Sex Steroids in the Effects of Immune System on Bone
Grčević, D., Kovačić, N., & Lee, S. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-800571-2.00012-8 · Cited by 2
The double-edged sword effect of estrogen in kidney disease and its precision modulation
Zhang, J., Lyu, J., Deng, M., Han, J., Wang, Q., Song, J., Zheng, R., & Bai, Z. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1819314 · Cited by 1
Role of Fas and RANKL Signaling in Peripheral Immune Tolerance
Izawa, T., Arakaki, R., & Ishimaru, N. (2017) · Journal of Clinical & Cellular Immunology · doi:10.4172/2155-9899.1000512 · Cited by 1
Self-citationHajati, A. (2010) · Figshare
Lard, L. R., & Huizinga, T. W. J. (2009) · RAED Dergisi
modulates particle-induced osteolysis.
Nich, C., Langlois, J., Marchadier, A., Vidal, C., Cohen-Solal, M. E., & Hamadouche, M. (2011)
Early Synovitis and Early Undifferentiated Arthritis
Mil, A. H. M. V. D. H., & Huizinga, T. W. J. (2013) · Elsevier eBooks · doi:10.1016/b978-1-4377-1738-9.00072-4
Early Synovitis and Early Undifferentiated Arthritis
Mil, A. H. M. V. D. H., & Huizinga, T. W. J. (2016) · Elsevier eBooks · doi:10.1016/b978-0-323-31696-5.00072-3
Bone remodeling during alveolar repair is impaired by RANKL antagonist
da Silva, A. C. E., Batista, F. R. D. S., de Moura, J., Coléte, J. Z., Chiba, F. Y., Gomes-Ferreira, P. H. S., & Okamoto, R. (2021) · Research Society and Development · doi:10.33448/rsd-v10i1.11975 · Cited by 1
“To support this, studies have shown that RANKL inibition by OPG decreased bone resorption in animals with estrogen deficiency (Yoneda et al., 2004; Kostenuik et al., 2001).”
Nagai, K., Ishii, T., & Nishii, Y. (2021) · Research Square · doi:10.21203/rs.3.rs-658268/v1
Metadata
- Authors
- Yoneda, T., Ishimaru, N., Arakaki, R., Kobayashi, M., Izawa, T., Moriyama, K., & Hayashi, Y.
- Affiliations
- Tokushima University (JP)
- Venue
- Endocrinology
- Publisher
- The Endocrine Society
- Published
- 2004-05-01
- Volume
- 145
- Issue
- 5
- Pages
- 2384-2391
- ISSN
- 0013-7227 (ISSN-L)
- 1945-7170
- OpenAlex
- W2109151234
- Cited by
- 60
- References
- 57
- Citations by year
- 2026: 1 · 2025: 2 · 2024: 3 · 2023: 1 · 2022: 2 · 2021: 4 · 2018: 1 · 2017: 3 · 2016: 1 · 2015: 3 · 2014: 1 · 2013: 5 · 2012: 3
- FWCI
- 2.59
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Endocrinology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Rheumatology › Rheumatoid Arthritis Research and Therapies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Keywords
- estrogen deficiency, rheumatoid arthritis, MRL/lpr mice, RANKL, osteoclastogenesis, ovariectomy, estrogen replacement therapy, osteoprotegerin, CD4+ T cells, autoantibodies, synovium, bone resorption, immune dysregulation
- MeSH terms
- Animals, Arthritis, Arthritis, Rheumatoid, Autoimmune Diseases, Bone Resorption, Carrier Proteins, Disease Models, Animal, Estrogens, Female, Glycoproteins, Joints, Membrane Glycoproteins, Osteoclasts, Ovariectomy, RNA, Messenger, Gene Expression, Cytokines, Receptors, Tumor Necrosis Factor, Receptors, Cytoplasmic and Nuclear, Matrix Metalloproteinase 3, Reverse Transcriptase Polymerase Chain Reaction, Matrix Metalloproteinase 9, Mice, Osteoprotegerin, RANK Ligand, Receptor Activator of Nuclear Factor-kappa B
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.